Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Sep 23;105(6):e214037.
doi: 10.1212/WNL.0000000000214037. Epub 2025 Aug 29.

Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults

Affiliations
Observational Study

Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults

Lana Chahine et al. Neurology. .

Abstract

Background and objectives: Parkinson disease (PD) pathology begins years before clinical diagnosis. Identifying individuals in this prodromal period is of high priority because they are candidates for clinical trials. Several characteristics of the PD prodrome have been described, but many are nonspecific. Among community-dwelling older adults unselected for PD risk, their relationship to objective measures of nigrostriatal dopaminergic nerve terminal density has not been studied in vivo. We determined prevalence of PD risk factors and prodromal signs/symptoms in community-dwelling older adults, examined their relationship with dopaminergic nerve terminal density, and explored prevalence and distribution of other possible prodromal features.

Methods: This was a cross-sectional observational study of community-dwelling older adults without diagnosed neurologic disorders in Southwestern Pennsylvania. Participants were assessed for 5 PD risk markers and ≤8 prodromal signs/symptoms, and underwent dopaminergic imaging with dihydrotetrabenazine ([11C](+)-α-DTBZ)-PET to assess nigrostriatal dopamine terminal density. Probability of prodromal PD based on Movement Disorders Society criteria was calculated. Possible prodromal PD (pPD) was defined as an estimated posterior probability for prodromal PD of >30%. The relationship between prodromal probability and age-adjusted and sex-adjusted [11C]DTBZ striatal binding was examined.

Results: A total of 231 participants were included, mean (SD) age 75.1 (4.5) years, 94 (40.7%) men. More than 1 prodromal sign/symptom was present in 131 (56.7%), with cognitive deficit being the most common. pPD was present in 18 (7.8%) of the sample. Compared with the not pPD group, the pPD group had lower mean age-adjusted and sex-adjusted predicted [11C]DTBZ posterior putamen binding (2.45 [0.119] vs 2.38 [0.150], p = 0.014) and greater left-right asymmetry (0.027 [0.006] vs 0.030 [0.007], p = 0.014). Hyposmia was significantly associated with lower posterior putamen binding compared with normosmia (β = -0.179, 95% CI -0.332 to -0.026, p = 0.022).

Discussion: Prodromal nonmotor and motor signs/symptoms of PD are common in community-dwelling older adults. Increased probability of prodromal PD is associated with decreased dopaminergic nerve terminal density of the posterior putamen that is also more asymmetric. Our findings support the use of composite measures of prodromal features to identify individuals at the population level who may be at risk for PD.

PubMed Disclaimer

Conflict of interest statement

The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

References

    1. GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(4):344-381. doi: 10.1016/S1474-4422(24)00038-3 - DOI - PMC - PubMed
    1. Seibyl JP, Kuo P. What is the role of dopamine transporter imaging in Parkinson prevention clinical trials? Neurology. 2022;99(7 suppl 1):61-67. doi: 10.1212/WNL.0000000000200786 - DOI - PubMed
    1. Simuni T, Chahine LM, Poston K, et al. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 2024;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2 - DOI - PubMed
    1. Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744-759. doi: 10.1093/brain/awz030 - DOI - PMC - PubMed
    1. Bramich S, King A, Kuruvilla M, Naismith SL, Noyce A, Alty J. Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies. J Neurol. 2022;269(9):4684-4695. doi: 10.1007/s00415-022-11213-9 - DOI - PMC - PubMed

Publication types

LinkOut - more resources